|
Originally published In Press as doi:10.1074/jbc.M202089200 on April 5, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24067-24072, July 5, 2002
Direct Interaction of Dermaseptin S4 Aminoheptanoyl Derivative
with Intraerythrocytic Malaria Parasite Leading to Increased Specific
Antiparasitic Activity in Culture*
Leah
Efron,
Arie
Dagan,
Leonid
Gaidukov,
Hagai
Ginsburg , and
Amram
Mor
From the Institute of Life Sciences, The Hebrew University of
Jerusalem, Givat Ram 91904 Jerusalem, Israel
Received for publication, March 4, 2002, and in revised form, March 25, 2002
 |
ABSTRACT |
Antiplasmodial activity of the dermaseptin S4
derivative K4S4(1-13) (P) was shown to be mediated
by lysis of the host cells. To identify antiplasmodial peptides with
enhanced selectivity, we produced and screened new derivatives based on
P and singled out the aminoheptanoylated peptide (NC7-P) for its
improved antiplasmodial properties. Compared with P, NC7-P displayed
both increased antiparasitic efficiency and reduced hemolysis,
including against infected cells. Antiplasmodial activity of P and its
derivative was time-dependent and irreversible, implying a
cytotoxic effect. But, whereas the dose dependence of growth inhibition
and hemolysis of infected cells overlapped when treated with P, NC7-P
exerted more than 50% growth inhibition at peptide concentrations that
did not cause hemolysis. Noticeably, NC7-P but not P, dissipated
the parasite plasma membrane potential and caused depletion
of intraparasite potassium at nonhemolytic conditions. Confocal
microscopy analysis of infected cells localized the rhodaminated
derivative in association with parasite membranes and intraerythrocytic
tubulovesicular structures, whereas in normal cells, the peptide
localized exclusively at the plasma membrane. Overall, the data
demonstrate that antimicrobial peptides can be engineered to act
specifically on the membrane of intracellular parasites and support a
mechanism whereby NC7-P crosses the host cell plasma membrane and
disrupts the parasite membrane(s).
 |
INTRODUCTION |
Malaria constitutes the most widespread infectious disease
affecting hundreds of million people, causing the death of one million
children every year in Africa alone (1). Because this dreadful
situation could worsen because of the increasing resistance of
parasites to available antiplasmodial drugs, new drugs must be developed.
Antimicrobial peptides have recently emerged as interesting tools for
exploring new antimalarial targets (2-6). These ubiquitous peptides
vary considerably in structure, size, amino acid sequence, and spectrum
of action (7-11), but the most potent peptides always have a
pronounced amphipathic and distinctly basic character (12-16). They
are believed to exert cytolytic action through their effect on the
membrane of target cells by a mechanism whose details remain to be
fully understood. Antimicrobial action is not mediated by interaction
with stereospecific targets such as receptors or enzymes (3, 17).
Apparently, their charge and hydrophobicity are the main features
affecting cytotoxicity (18-20). Some antimicrobial peptides were
stipulated to form ion channels or pores (21, 22). Various basic models
for a membranolytic mechanism were proposed ranging from pore formation
to induction of structural defects (20-27) that lead to membrane
permeabilization. Consequently, essential ions and metabolites are free
to leak in and out and to dissipate the electric potential across the
membrane, eventually leading to cell death.
Antimicrobial peptides often display a broad spectrum of activity
affecting Gram-negative and Gram-positive bacteria, yeast and
filamentous fungi, some enveloped viruses, and many types of cancer
cells. Yet many are relatively inactive on normal eukaryotic cells
(28-30). Although the basis for this discrimination is also unclear,
it appears to be related to the lipid composition of the target
membrane (i.e. fluidity, negative charge density, and the
absence or presence of cholesterol) and the presence in the peptide-susceptible organisms of a large negative
trans-membrane electrical potential (31-34). Such a
peptide-based antimicrobial system has attractive advantages over
classical antibiotics because it makes it extremely difficult for
microbial targets to develop resistance (15, 35, 36). Nevertheless, a
major drawback of such an antimicrobial system is reflected in its
unselective activity over a wide range of cell types, which could be
problematic, for instance, in systemic routes of administration
(37).
Dermaseptin S4 is a 28-residue antimicrobial peptide isolated from frog
skin (38). The native peptide was shown to exert antiplasmodial
activity (4), whereas subsequent studies (17, 39) identified a
13-residue derivative, K4-S4(1-13), displaying a
considerable in vitro effectiveness on Plasmodium
falciparum, the most lethal human parasite (5). The antiplasmodial
action was rapid and was shown to be mediated by permeabilization of host cell plasma membrane. Although K4-S4(1-13) was less
hemolytic to normal erythrocytes, it was deemed necessary to develop
additional derivatives that could affect the parasite with minimal
threat to erythrocytes. Recently, acyl derivatives of
K4-S4(1-13) were shown to increase antiplasmodial
activity, although the most potent antiparasitic peptides still
displayed high hemolytic activity (6). In this study, a series of new
dermaseptin S4 derivatives based on K4-S4(1-13) were
produced and investigated for antiplasmodial and hemolytic properties.
After screening for the most selective compound, we investigated its
detailed mechanism of action.
 |
MATERIALS AND METHODS |
Synthesis of Dermaseptin S4 Derivatives--
The reference
peptide K4-S4(1-13) was synthesized by the solid phase
method, applying the Fmoc1
active ester chemistry on a fully automated, programmable peptide synthesizer (model 433A; Applied Biosystems) as described (17) with the
following modifications. 4-Methylbenzhydrylamine resin (Novabiochem) was used to obtain amidated peptides. The various analogs were prepared by linking the N terminus of
K4-S4(1-13) to one of the compounds detailed in Table I as
follows. After removing the Fmoc group (20%
piperidine/N-methylpyrrolidone), the resin-bound peptide (20 mg) was suspended in 0.7 ml of dimethylformamide to which a 2-fold
molar excess of the relevant tert-butyloxyl-carbonyl protected aminocarboxylic acid was added followed by 3-fold molar excess of 1-ethyl-3-(dimethylaminopropyl)carbodiimide. In the specific
case of t-BOC aminolauric acid, reactants were mixed in
dimethylformamide/CH2Cl2 (1:1). The reaction
mixture was sonicated for 5 min and then agitated for 24 h at room
temperature. The resin was washed with dimethylformamide and then with
ether/dichloromethane (1:1) and dried for 4 h at 50 °C. For
visualization studies, rhodamine was covalently attached to the
deprotected N terminus of NC6-P (Table I) while still linked to the
resin. Peptide labeling, cleavage from the resin, and purification by
HPLC were also performed as described (17). The purified peptides were
subjected to amino acid analysis and mass spectrometry to confirm their
composition. Peptides were stocked as lyophilized powder at 20 °C.
Prior to testing, fresh solutions were prepared in water, briefly
vortexed, sonicated, centrifuged, and then diluted in the appropriate medium.
Determination of Hemolytic Potential--
Human blood was rinsed
three times in PBS (50 mM sodium phosphate, 150 mM NaCl, pH 7.3) by centrifugation for 1 min at 2700 × g, and then 2.5 × 108 red blood cells
(RBC) suspended in 50 µl PBS were added to Eppendorf test tubes
containing 200 µl of peptide solutions (serial 2-fold dilutions in
PBS), PBS alone (for baseline values), or distilled water (for 100%
hemolysis). After incubation (3 h under agitation, 37 °C) the
samples were centrifuged, and the hemolytic activity was assessed as a
function of hemoglobin leakage by measuring the absorbance of 200 µl
of supernatant (405 nm). The statistical data were obtained from at
least three independent experiments performed in duplicate.
Parasite Cultivation--
The W2 strain of P. falciparum was cultivated as described (40) using human RBC. The
culture was synchronized by the sorbitol method (41) using the less
toxic alanine, and infected cells were enriched from culture by
Percoll-alanine gradient centrifugation (40).
Drug Screening Test--
Synchronized cultures at the ring stage
were cultured at 1% hematocrit and 2% parasitemia in the
presence of 10 µM of dermaseptin derivatives. After
18 h of incubation, parasite viability was determined by
[3H]hypoxanthine (Hx) uptake (final concentration, 2 µCi/ml) during 6 h and compared with controls (without peptide).
Parallel cultures were tested after 6 h for hemolysis as
determined by hemoglobin absorbance at 405 nm and compared with cells
lysed in water.
Determination of IC50--
Parasite viability in the
presence of increasing peptide concentrations was determined as
described above. The 50% inhibitory concentration (IC50)
was determined by nonlinear regression fitting of the data using
Sigmaplot. The same procedures were used for the measurement of
parasite viability and hemolysis and the stage and the time dependence
of drug effect at the different stages.
Peptide-mediated Dissipation of Parasite Membrane
Potential--
Trophozoite stage culture in modified growth medium
(wash medium containing 10 mM bicarbonate and 7% plasma)
at 0.5% hematocrit was incubated in the presence of 1 µM
rhodamine 123 for 30 min at 37 °C. Rhodamine 123 accumulates inside
cells in proportion to the membrane potential ( ) and has
been shown to respond to the dissipation of the plasma membrane 
in P. falciparum (42). Aliquots of this culture were then
exposed to P, NC7-P, or a mixture of 10 µM nigericin
(K+:H+ exchanger) and 10 µM
monensin (Na+:H+ exchanger) to dissipate the
ion gradient across membranes (positive control). The samples were
taken at different time intervals, and the cells were washed in PBS and
resuspended in original sample volume of PBS. Aliquots of 120 µl were
placed in a 96-well plate and read in a fluorescence reader
(excitation wavelength ex = 530 nm, emission wavelength
em = 585 nm). Relative fluorescence (as a percentage of
that of the untreated control at the same time) was plotted against the
time of incubation.
Peptide-mediated Depletion of Parasite Intracellular
Potassium--
Infected cells at the young trophozoite stage were
enriched from culture using the Percoll-alanine gradient (97%
parasitemia, determined on Giemsa-strained thin blood smears) and
incubated at 0.5% hematocrit in culture medium at 37 °C, with or
without 10 µM P or NC7-P. At time 0 and after 4 h,
aliquots were taken, cells were washed in PBS, and parasites were freed
by saponine (0.003% w/v in PBS)-induced lysis for several minutes at
room temperature. The parasites were washed several times in PBS and finally washed with 110 mM MgCl2 buffered with
10 mM Hepes. The parasites were disrupted by freezing and
thawing, and potassium content in the supernatant was determined by
inductive-coupled plasma atomic emission spectroscopy on an Optima 3300 Inductively coupled plasma atomic emission spectroscopy system
(PerkinElmer Life Sciences).
Intracellular Localization of Fluorescent Peptide by Confocal
Microscopy--
Cultures (1% hematocrit) of trophozoites (~ 90%
parasitemia) and uninfected human erythrocytes were incubated in the
presence of the rhodaminated peptide at 1 and 10 µM.
After 15 and 120 min, the cells were washed and analyzed. In control
experiments, the cells were incubated in the presence of free rhodamine
and unlabeled NC7-P under similar conditions. Confocal microscope
images of the samples (nonfixed cells) were taken using an MRC 1024 confocal imaging system (Bio-Rad). The microscope (Axiovert 135M;
Zeiss) is equipped with a 63× objective (Apoplan; NA 1,4). For
rhodamine excitation, an Argon ion laser adjusted at 514 nm
(emission wavelength = 580 ± 32 nm) was used.
 |
RESULTS |
To reduce hemolytic activity, acylated peptides (6) were converted
to aminoacyl derivatives. Identity of the synthetic products (Table
I) was confirmed by mass analysis of the
HPLC-purified peptides (purity was > 95%). As shown in Fig.
1A, acylation of P resulted in
increased hydrophobicity concomitant with increased acyl chain length.
Comparatively, aminoacyl analogs had reduced hydrophobicity, presumably
because of their increased polarity. Fig. 1B shows that
increased hydrophobicity of acyl derivatives first counteracts the
hemolytic activity of the parent peptide (as measured in PBS) and
thereafter increases it. The aminoacyl derivatives display similar
biphasic effect albeit at considerably higher concentrations. It is
suggested that the biphasic effect results from the opposing forces of
membrane solubilization (enhanced by acyl chain length) and
surface aggregation (essential for hemolytic activity)
(11).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Hydrophobicity and hemolytic potential of two
groups of acyl-peptides. A shows the effect of chain length
on hydrophobicity, measured as function of the acetonitrile
(ACN) concentration required for elution of acyl ( ) and
aminoacyl ( ) derivatives, using a linear gradient of acetonitrile
(1%/min) in reversed-phase HPLC with a C4 column. B shows
the peptide concentrations that produced 50% hemolysis after 3 h
of incubation in PBS. The error bars represent the
standard deviations from the mean calculated from at least
two independent experiments performed in duplicate. If no error bar is
shown, the standard deviation was smaller than the diameter of the
symbol.
|
|
Screen of Antiplasmodial and Hemolytic Activities--
To identify
peptides that will selectively kill the parasite without lysis of the
host cell, the aminoacyl peptides were screened at a single dose of 10 µM for antiplasmodial and hemolytic activities. All of
the peptides tested inhibited plasmodial growth to various extents.
But, whereas derivatives with short hydrocarbon chains had either lower
(e.g. NC2-P) or similar (e.g. NC4-P)
antiplasmodial activity compared with the parent peptide P, the more
hydrophobic peptides NC7-P and NC12-P were more active (Fig.
2a). Yet although derivatives
with 2-7 hydrocarbons (NC2-P, NC4-P, and NC7-P) were less hemolytic,
NC12-P displayed increased hemolytic action (Fig. 2b). To
select for the most suitable derivative, we compared the ratio of
relative inhibition to relative hemolysis. This analysis (Fig.
2c) revealed that NC4-P and NC7-P were the most selective, i.e. the antiplasmodial activity was superior to the
hemolytic action.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 2.
Screen of antiplasmodial and hemolytic
activities. Synchronized cultures at the ring stage (2%
parasitemia) were cultured in the presence of the designated peptides.
After 24 h of incubation, the cultures were divided into two sets.
To one set Hx was added, and cell-associated radioactivity was
determined and compared with controls (a). The second set
was used to determine the concentration of hemoglobin in the
supernatant compared with fully hemolyzed cultures (b). The
error bars represent the standard deviations from the mean,
calculated from at least two independent experiments performed in
quadruplicate. c shows the ratio of a/b
calculated from the mean values of a and b.
|
|
Two additional branched derivatives (N2C6-P and N4C9-P) were prepared
to assess the effect of modulating the charge and hydrophobicity. Compared with P, N2C6-P did not display improved antiplasmodial activity but resulted in increased hemolysis, whereas N4C9-P displayed reduced antiplasmodial and hemolytic activities (Fig. 2, a
and b). Because NC7-P combined both increased
antiplasmodial effect with lower hemolysis compared with P
(as reflected by the increased ratio of the percentage of inhibition to
the percentage of lysis in Fig. 2c), this derivative was
chosen for further and more detailed investigations.
Detailed Determination of Antiplasmodial Activity and Stage
Dependence of Selected Compounds--
The dose response of NC7-P was
investigated and compared with the parent peptide P using synchronized
cultures of P. falciparum that were exposed to the peptides
either at the ring or at the trophozoite stage. NC7-P was more
effective than P at the ring stage (IC50 = 5.3 ± 0.7 and 7.7 ± 0.9 µM, respectively), but the opposite
was observed for the trophozoite stage (IC50 = 6.2 ± 0.5 and 3.4 ± 0.3 µM, respectively). The stage
dependence results indicated that ring stage parasites were less
sensitive to P, as previously observed (5), than the more mature
trophozoite stage. This was not observed with NC7-P. Moreover, the
slopes of the dose-response curves were slightly higher for NC7-P
(1.9 ± 0.5 and 2.3 ± 0.4, respectively) compared with P
(1.5 ± 0.2 and 1.4 ± 0.1, respectively), indicating some
differences in the stoichiometry of drug and target relations.
Time Dependence and Reversibility of Antiplasmodial
Action--
NC7-P (10 µM) was found to be similarly
active, and its action was time-dependent both for ring and
trophozoite stages, displaying maximal activity after 24 h of
exposure (Fig. 3). Removal of the peptide
from the culture after 5 h of incubation and measuring parasite
viability 19 h later, revealed that the antiplasmodial effect
proceeded further even in the absence of peptide in the medium. These
results suggest that internalized peptide (see below) could not be
removed from the cells and that the antiplasmodial effect was
cytotoxic.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Stage dependence of the antiplasmodial
activity. Infected cells were exposed to NC7-P, and parasite
growth was determined by Hx incorporation using one of the following
procedures. Columns A, exposure to NC7-P (5 h) was followed
by wash and Hx incorporation (5 h). Columns B, exposure to
NC7-P (5 h) was followed by wash, recovery without peptide (19 h), and
Hx incorporation (5 h). Columns C, exposure to NC7-P (24 h)
was followed by wash and Hx incorporation (5 h). Columns D,
exposure to NC7-P (29 h) was directly followed by Hx incorporation (5 h). Each experiment was performed twice in duplicate. The error
bars represent the standard deviations from the mean.
|
|
Hemolytic Activity versus Antiplasmodial Activity--
To further
understand the mechanism of antiplasmodial activity, P and NC7-P were
tested simultaneously for their hemolytic and antiplasmodial
activities. Infected cells at the young trophozoite stage were enriched
(~90% parasitemia) from culture and exposed (0.5% hematocrit) to
increasing peptide concentrations. Parasite viability was determined
after 2 h of exposure to peptides followed by 4 h of exposure
to hypoxanthine in culture conditions, whereas hemolysis was assayed on
normal and infected erythrocytes after 6 h of exposure to the
peptide. Under these conditions of short time exposure of
trophozoite-enriched cultures, NC7-P was more inhibitory than P
(IC50 = 14.2 ± 0.5 and 19.6 ± 1.6 µM, respectively). Yet NC7-P was much less hemolytic than
P to infected erythrocytes (LC50 = >60 and 21.2 ± 0.6 µM, respectively), whereas this discrepancy was less
pronounced for uninfected cells (Fig.
4).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Hemolytic activity versus
antiplasmodial activity. Infected (iRBC) and
uninfected cells (nRBC) were cultured with peptides for
2 h and then with Hx for 4 h, and the cell-associated
radioactivity was determined on one set (a). Hemolysis was
determined after 6 h of incubation in two additional sets of
cultured infected RBC (b) and uninfected RBC (c).
, P; , NC7-P. Each experiment was performed at least
twice in quadruplicate. The error bars represent the
standard deviations from the mean. If no error bar is shown, the
standard deviation was smaller than the diameter of the symbol.
|
|
Peptide-mediated Dissipation of the Parasite Plasma Membrane
Potential and Induced Leak of Intraparasite Potassium--
The
fluorescent dye rhodamine 123 accumulates in parasites in correlation
with the parasite membrane  , and permeabilization of the parasite
membrane by the peptide is expected to reduce  and thus dye
accumulation, as attested by the effect of the ionophores nigericin and
monensin (Fig. 5a). No
dissipation of  was observed with P, whereas NC7-P caused a
discernible reduction. Moreover, exposure of infected cells (~90%
parasitemia) to 10 µM peptides and measurement of
potassium content in saponin-freed parasites revealed no effect of P
and a marked reduction in the presence of NC7-P (Fig. 5b).
The congruity of both types of results clearly indicates that at
nonhemolytic concentrations NC7-P but not P can cross the host cell
membrane without upsetting it and interact with the parasite plasma
membrane to permeabilize it.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Peptide-mediated dissipation of parasite
membrane potential and depletion of parasite intracellular
potassium. a, trophozoites (97% parasitemia)
preincubated with rhodamine 123 were exposed to PBS ( ), P ( ), or
NC7-P ( ) or to a mixture of known ionophores: nigericin + monensin
( ). The samples were taken at different time intervals, washed, and
resuspended in the original sample volume of PBS. Their relative
fluorescence (as the percentage of untreated control at the same time)
is plotted against the time of exposure. b, infected cells
were cultured in absence (black bar) or presence of P
(gray bar) or NC7-P (white bar), and parasites
were freed from their host cell by saponin lysis. Free parasites were
disrupted by freezing and thawing, and the potassium content in the
supernatant was determined by inductively coupled plasma atomic
emission spectroscopy. The results are shown as percentages of
potassium content relative to control at time 0. Each experiment was
performed twice in duplicate. The error bars represent the
standard deviations from the mean.
|
|
Subcellular Localization of the Peptide Using a Rhodaminated
Derivative--
A fluorescent peptide where rhodamine was covalently
linked to the N terminus of the peptide was prepared and compared with NC7-P with respect to antiplasmodial and hemolytic activities as
described above. The rhodaminated peptide had similar antiplasmodial activity, but it was considerably more hemolytic than NC7-P (data not
shown). Inspection by confocal microscopy (mid-depth Z slice) of
uninfected human erythrocytes exposed to 1 or 10 µM
labeled peptide for up to 2 h under culture conditions revealed
intense labeling of many cells (Fig.
6a). The dye was seen
associated exclusively with the erythrocyte membrane. Fluorescence
intensity increased with concentration, but the number of labeled cells remained practically unchanged with time (not shown). Similar exposure
of trophozoite-infected human erythrocytes (~90% parasitemia) labeled many more cells with the same pattern of dose and time dependence seen with uninfected erythrocytes (Fig. 6b).
Further magnifications disclosed that the label was specifically
localized in the parasites and that labeling existed in the host
compartment of inclusions that can be identified as tubulovesicular
structures and Maurer's clefts. In control experiments where the cells
were incubated under similar conditions but in the presence of 10 µM free rhodamine and 10 µM unlabeled
NC7-P, neither the infected nor the normal cells were labeled.

View larger version (127K):
[in this window]
[in a new window]
|
Fig. 6.
Localization of the fluorescent peptide by
confocal microscopy. Normal human erythrocytes and trophozoites
(~90% parasitemia) were exposed to the rhodaminated peptide and then
washed and analyzed unfixed by confocal microscopy. Three zoom levels
of the same microscopic field are shown (increasing from top
to bottom). Each zoom level shows both the
fluorescence (left column) and the light transmission
(right column) of the same image for normal (a)
and infected cells (b).
|
|
 |
DISCUSSION |
To design dermaseptin derivatives with greater selectivity, we
have been guided by the following rationale. Selective activity of
antimicrobial peptides demonstrably depends on the membrane lipid
composition (17-27). The lipid composition of the infected cell is
considerably different from that of uninfected erythrocytes and other
somatic cells of the host in that it is devoid of cholesterol and it
has considerably less sphingomylin and phosphatidyl serine, larger concentrations of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, and a decreased level of unsaturation of
the fatty acids (43). Although the lipid compositions of host and
parasite membrane are similar, the potential of the parasite membrane
is considerably higher than that of the host cell membrane (42), and it
is in the right polarity needed for enhancement of peptide
incorporation (32-34). Thus, we hypothesized that the discriminating
effect of the dermaseptin derivative could be exerted on two
additional levels: (i) preference for infected cells because of lipid
composition and (ii) the preference for the parasite membrane because
of favorable  once inside the cytosol of the infected cell.
Increasing the lipophilicity of the peptide will render it more
permeable through the host cell membrane and therefore more accessible
to the parasite membrane. Because this feature also increases hemolytic
activity (6, 17), we have used aminoacyl moieties to reduce
hydrophobicity and, hence, the risk for hemolysis.
This reasoning has been tested experimentally using seven peptides of
varying N termini. For all derivatives the antiplasmodial and hemolytic
activities were found to depend on the nature of the added moiety.
Sorting the derivatives by their selectivity (ratio of the percentage
of inhibition to the percentage of hemolysis), NC7-P was singled out as
the most selective and was further used in parallel with the parent
peptide P for detailed investigations. To acquire a deeper
understanding of the selectivity effect, parallel determination of
antiplasmodial activity and lysis of normal and infected erythrocytes
were conducted for short incubation times. The IC50 values
obtained in these experiments were understandably higher than those
obtained in the standard dose-response test that lasted 24 h
because of the time dependence effect and the increased number of
infected cells (from 2 to ~90%, respectively). Outstandingly,
whereas with P the dose dependence of growth inhibition and lysis of
infected cells overlapped, with NC7-P more than 50% growth inhibition
occurred at concentrations that did not cause lysis at all. This
discrepancy is possibly even larger because both growth inhibition and
lysis are time-dependent processes, and exposure to
peptides was only 2 h in the first case and 6 h in the
second. Noticeably, whereas P was more lytic to infected cells than to
uninfected cells, such discrepancy was much less pronounced for NC7-P.
This is a further demonstration of the lipid-dependent specificity of peptides.
Unlike P (5), NC7-P was not stage-selective, being equally inhibitory
for both the young ring stage and the more mature trophozoites. We
propose that P acts essentially by lysing the host cell membrane. It is
more lytic to host cells harboring mature parasite stages, indicating
dependence on changes induced by parasite in the host cell membrane.
Because the latter evolves with parasite maturation, throphozoites are
expected to be more sensitive than rings, as was found (5). In
contrast, the selectivity of the NC7-P seems to depend on the
differential  of host and parasite membrane. Because this is
established from the onset of parasite development, the permeable
peptide is always sucked into the parasite membrane and affects it. For
this reason stage dependence with NC7-P is neither expected nor observed.
The antiplasmodial effect of NC7-P was clearly
time-dependent. It was found to have a stage-independent
cytotoxic activity that persisted and accrued even when it was
discarded from the culture. This indicates that the association of
NC7-P with the parasite membrane is essentially irreversible and that
even without saturation of the putative peptide binding sites, it
results in the continuous loss of the parasites viability because of
membrane permeabilization. The interaction of a fluorescent analog of
NC7-P with uninfected erythrocytes was seen to be localized at the cell membrane. However, we cannot exclude the possibility that if the peptide was internalized, its fluorescence was quenched by hemoglobin. In infected cells, the fluorescent analog reached the parasite and
labeled its plasma membrane and the tubulovesicular network that
emerges from the parasitophorous vacuolar membrane and extends to the
erythrocyte membrane (44, 45). The high resolution images obtained by
fluorescence confocal microscopy recall the subcellular distribution of
the fluorescent phospholipid NBD-PC (46), attesting to the association
of the peptide with the membranes of the infected cell.
Parenthetically, the staining of a subpopulation of infected cells
conforms with partial inhibition of parasite growth as measured by the
hypoxanthine viability assay that integrates the response of the entire
parasite population. To the best of our knowledge, this is the first
demonstration ever of an antiplasmodial compound that acts on a
subpopulation of cells in an all-or-none fashion rather than reducing
vital processes in each cell.
The lipophilic and membrane-trophic character of NC7-P insinuates that
its interaction with the parasite membrane would lead to nonselective
permeabilization. The observed dissipation of  could result from
increased permeability to protons because the major generator of 
is presumably the V-type H+ pump (47, 48). Permeabilization
to protons undercuts the function of the pump as the major regulator of
cellular pH. Short circuiting of the electrogenic function of the pump
presumably underlies the observed loss of cellular potassium, the
maintenance of which seems to depend on  . Although these
presumptions could explain the gradual and irreversible loss of vital
cellular functions, we cannot exclude at the present time the
possibility that NC7-P acts on a different cellular target that
mediates its cytotoxic action.
In conclusion, we demonstrate in this investigation that membrane
active peptides can be engineered to act specifically on the membrane
of the intracellular parasite to perturb its functions. This selective
activity reduces the potential harm from inadvertent lysis of the
erythrocytes of the host. This is a major achievement in the fine
tuning of peptide composition toward its further development as a
potential antimalarial drug. It has been shown previously that
intravenous administration of P to rats was well tolerated at least up
to 10 mg/kg (39) and that the LD50 of S4 derivatives (including P) administered intraperitoneally in mice was 25 mg/kg, whereas effectiveness against Pseudomonas aeruginosa-induced
peritonitis was achieved at 4.5 mg/kg (49). Because NC7-P is less
hemolytic than P, it can be assumed that it will be less toxic in
vivo. Such concentrations are substantially higher than the
IC50 of NC7-P against the malaria parasite, indicating that
it could also be effective in vivo. It remains to be shown
experimentally that NC7-P is not toxic to mammalian cells or to whole
animals and that its antiplasmodial effect is maintained in
vivo. Investigations of these aspects are underway in our laboratory.
 |
ACKNOWLEDGEMENTS |
The expert assistance of Dr. Naomi Melamed
and Josephina Silfen (Hebrew University) in confocal microscopy and
peptide synthesis, respectively, is gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by Israel Science Foundation Grant
523/98.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biological
Chemistry, Inst. of Life Sciences, The Hebrew University of Jerusalem,
Givat Ram 91904 Jerusalem, Israel. E-mail:
hagai@vms.huji.ac.il.
Published, JBC Papers in Press, April 5, 2002, DOI 10.1074/jbc.M202089200
 |
ABBREVIATIONS |
The abbreviations used are:
Fmoc, N-(9-fluorenyl)methoxycarbonyl;
RBC, red blood cells;
PBS, phosphate-buffered saline;
Hx, hypoxanthine;
P, K4-S4(1-13);
HPLC, high performance liquid
chromatography.
 |
REFERENCES |
| 1.
| World Health Organization (1999) Disease Statistics World
Health Report, www.who.int/whr/1999/en/disease.htm
|
| 2.
|
Jaynes, J. M.,
Burton, C. A.,
Barr, S. B.,
Jeffers, G. W.,
Julian, G. R.,
White, K. L.,
Enright, F. M.,
Klei, T. R.,
and Laine, R. A.
(1988)
FASEB J.
2,
2878-2883[Abstract]
|
| 3.
|
Wade, D.,
Boman, A.,
Wahlin, B.,
Drain, C. M.,
Andreu, D.,
Boman, H. G.,
and Merrifield, R. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4761-4765[Abstract/Free Full Text]
|
| 4.
|
Ghosh, J. K.,
et al..
(1997)
J. Biol. Chem.
272,
31609-31616[Abstract/Free Full Text]
|
| 5.
|
Krugliak, M.,
Feder, R.,
Zolotarev, V.,
Gaidukov, L.,
Dagan, A.,
Ginsburg, H.,
and Mor, A.
(2000)
Antimicrob. Agents Chemother.
44,
2442-2451[Abstract/Free Full Text]
|
| 6.
|
Dagan, A.,
Efron, L.,
Gaidukov, L.,
Mor, A.,
and Ginsburg, H.
(2002)
Antimicrob. Agents Chemother.
46,
1059-1066[Abstract/Free Full Text]
|
| 7.
|
Ganz, T.,
and Lehrer, R.
(1998)
Curr. Opin. Immunol.
10,
41-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Hancock, R. E. W.,
and Chapple, D. S.
(1999)
Antimicrob. Agents Chemother.
43,
1317-1323[Free Full Text]
|
| 9.
|
Levy, O.
(2000)
Blood
96,
2664-2672[Abstract/Free Full Text]
|
| 10.
| Mor, A. (2001) The Kirk-Othmer Encyclopedia of Chemical
Technology,
www.mrw.interscience.wiley.com/kirk/articles/peptwise.a01/frame.html
|
| 11.
|
Zasloff, M.
(2002)
Nature
415,
389-395[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Maloy, L. W.,
and Kari, U. P.
(1995)
Biopolymers
37,
105-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nicolas, P.,
and Mor, A.
(1995)
Annu. Rev. Microbiol.
4,
277-304[CrossRef]
|
| 14.
|
Tossi, A.,
Sandri, L.,
and Giangaspero, A.
(2000)
Biopolymers
55,
4-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Chen, J.,
Falla, T. J.,
Liu, H. J.,
Hurst, M. A.,
Fujii, C. A.,
Mosca, D. A.,
Embree, J. R.,
Loury, D. J.,
Radel, P. A.,
Chang, C. C., Gu, L.,
and Fiddes, J. C.
(2000)
Biopolymers.
55,
88-98[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Blondelle, E. S.,
and Lohner, K.
(2000)
Biopolymers
55,
74-87[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Feder, R.,
Dagan, A.,
and Mor, A.
(2000)
J. Biol. Chem.
275,
4230-4238[Abstract/Free Full Text]
|
| 18.
|
Mor, A.,
Hani, K.,
and Nicolas, P.
(1994)
J. Biol. Chem.
269,
31635-31641[Abstract/Free Full Text]
|
| 19.
|
Strahilevitz, J.,
Mor, A.,
Nicolas, P.,
and Shai, Y.
(1994)
Biochemistry
33,
10951-10960[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Oren, Z.,
and Shai, Y.
(1998)
Biopolymers
47,
451-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Sokolov, Y.,
Mirzabekov, T.,
Martin, D. W.,
Lehrer, R. I.,
and Kagan, B. L.
(1999)
Biochim. Biophys. Acta
1420,
23-29[Medline]
[Order article via Infotrieve]
|
| 22.
|
Yang, L.,
Weiss, T. M.,
Lehrer, R. I.,
and Huang, H. W.
(2000)
Biophys. J.
79,
2002-2009[Abstract/Free Full Text]
|
| 23.
|
Milik, M.,
and Skolnick, J.
(1993)
Proteins
15,
10-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Shai, Y.
(1995)
Trends Biochem. Sci.
20,
460-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
White, S. H.,
and Wimley, W. C.
(1998)
Biochim. Biophys. Acta.
1376,
339-352[Medline]
[Order article via Infotrieve]
|
| 26.
|
Huang, H. W.
(2000)
Biochemistry
39,
8347-8352[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Uematsu, N.,
and Matsuzaki, K.
(2000)
Biophys. J.
79,
2075-2083[Abstract/Free Full Text]
|
| 28.
|
Mor, A.,
and Nicolas, P.
(1994)
J. Biol. Chem.
269,
1934-1939[Abstract/Free Full Text]
|
| 29.
|
Martin, E.,
Ganz, T.,
and Lehrer, R. I.
(1995)
J. Leukocyte Biol.
58,
128-136[Abstract]
|
| 30.
|
Soballe, P. W.,
Maloy, W. L.,
Myrga, M. L.,
Jacob, L. S.,
and Herlyn, M.
(1995)
Int. J. Cancer.
60,
280-284[Medline]
[Order article via Infotrieve]
|
| 31.
|
Andreu, D.,
and Rivas, L.
(1998)
Biopolymers
47,
415-433[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Cruciani, R. A.,
Barker, J. L.,
Zasloff, M.,
Chen, H. C.,
and Colamonici, O.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3792-3796[Abstract/Free Full Text]
|
| 33.
|
Matsuzaki, K.,
Sugishita, K.,
Fujii, N.,
and Miyajima, K.
(1995)
Biochemistry
34,
3423-3429[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Diaz-Achirica, P.,
Ubach, J.,
Guinea, A.,
Andreu, D.,
and Rivas, L.
(1998)
Biochem. J.
330,
453-460
|
| 35.
|
Lamb, H. M.,
and Wiseman, L. R.
(1998)
Drugs
56,
1047-1054[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Mor, A.
(2001)
Drug Dev. Res.
50,
440-447[CrossRef]
|
| 37.
|
Gura, T.
(2001)
Science.
291,
2068-2071[Free Full Text]
|
| 38.
|
Mor, A.,
and Nicolas, P.
(1994)
Eur. J. Biochem.
219,
145-154[Medline]
[Order article via Infotrieve]
|
| 39.
|
Feder, R.,
Nechushtai, R.,
and Mor, A.
(2001)
Peptides
22,
1683-1690[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kutner, S.,
Breuer, W. V.,
Ginsburg, H.,
Aley, S. B.,
and Cabantchik, Z. I.
(1985)
J. Cell. Physiol.
125,
521-527[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Lambros, C. J.,
and Vanderberg, J. P.
(1979)
J. Parasitol.
65,
418-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Tanabe, K.,
Izumo, A.,
Kato, M.,
Miki, A.,
and Doi, S.
(1989)
J. Protozool.
36,
139-143[Medline]
[Order article via Infotrieve]
|
| 43.
|
Vial, H. J.,
and Ancelin, M. L.
(1998)
in
Malaria: Parasite Biology, Pathogenesis and Protection
(Sherman, I. W., ed)
, pp. 159-175, ASM Press, Washington, D.C.
|
| 44.
|
Elmendorf, H. G.,
and Haldar, K.
(1994)
J. Cell Biol.
124,
449-462[Abstract/Free Full Text]
|
| 45.
|
Elford, B. C.,
and Ferguson, D. J.
(1993)
Parasitol. Today
9,
80-81[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Grellier, P.,
Rigomier, D.,
Clavey, V.,
Fruchart, J.,
and Schrevel, J.
(1991)
J. Cell Biol.
112,
267-277[Abstract/Free Full Text]
|
| 47.
|
Mikkelsen, R. B.,
Tanabe, K.,
and Wallach, D. F.
(1982)
J. Cell Biol.
93,
685-689[Abstract/Free Full Text]
|
| 48.
|
Saliba, K. J.,
and Kirk, K.
(1999)
J. Biol. Chem.
274,
33213-33219[Abstract/Free Full Text]
|
| 49.
|
Navon-Venezia, S.,
Feder, R.,
Gaidukov, L.,
Carmeli, Y.,
and Mor, A.
(2002)
Antimicrob. Agents Chemother.
46,
689-694[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Mason, W. Moussaoui, T. Abdelrahman, A. Boukhari, P. Bertani, A. Marquette, P. Shooshtarizaheh, G. Moulay, N. Boehm, B. Guerold, et al.
Structural Determinants of Antimicrobial and Antiplasmodial Activity and Selectivity in Histidine-rich Amphipathic Cationic Peptides
J. Biol. Chem.,
January 2, 2009;
284(1):
119 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Radzishevsky, M. Krugliak, H. Ginsburg, and A. Mor
Antiplasmodial Activity of Lauryl-Lysine Oligomers
Antimicrob. Agents Chemother.,
May 1, 2007;
51(5):
1753 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rotem, I. Radzishevsky, and A. Mor
Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.
Antimicrob. Agents Chemother.,
August 1, 2006;
50(8):
2666 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Shalev, S. Rotem, A. Fish, and A. Mor
Consequences of N-Acylation on Structure and Membrane Binding Properties of Dermaseptin Derivative K4-S4-(1-13)
J. Biol. Chem.,
April 7, 2006;
281(14):
9432 - 9438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rydlo, S. Rotem, and A. Mor
Antibacterial Properties of Dermaseptin S4 Derivatives under Extreme Incubation Conditions
Antimicrob. Agents Chemother.,
February 1, 2006;
50(2):
490 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. VanCompernolle, R. J. Taylor, K. Oswald-Richter, J. Jiang, B. E. Youree, J. H. Bowie, M. J. Tyler, J. M. Conlon, D. Wade, C. Aiken, et al.
Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells
J. Virol.,
September 15, 2005;
79(18):
11598 - 11606.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|